Research & Development: Page 79
-
PharmaVoice Team/PharmaVoice
Global Harmony Comes to Drug Development
That document — called the common technical document or CTD — is now being accepted by regulatory agencies in the United States, Europe, and Japan as part of a transition phase. Consensus was reached by the international pharmaceutical community in May of this year. This document will eventually ...
By Denise Myshko • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES RapidTrials.com, launched by PCRS Inc., is the first Webbased platform to provide realtime bench mark metrics on trial progress for research centers. The pro gram helps drive revenue, study programs, and marketing research projects...
By PharmaVoice Team • Feb. 12, 2009 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES The OmniLog ID Microbial Identification System, which includes proprietary software and sophisticat ed hardware, is designed to automate and simplify the process of characterizing and identifying a wide range of aerobic bacteria. ...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
6 J u l y / A u gu s t 20 01 PharmaVOICE CSOs: Not just hired guns Contract sales organizations have come a long way to stay a step ahead of their clients’ needs 34 Unleashing the power of Nexium AstraZeneca marketers are positioning the company’s new proton pump inhibitor to replace Prilosec, th...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
CSOs: Not Just Hired Guns
Contract sales organizations have come a long way to stay one step ahead of their clients’ needs. Today, the contract sales industry is more than putting bodies in motion. No longer are contract sales organizations just “hired guns” employed for a temporary territory fix. Since 1995, when contrac...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
Making Investigators Top of Mind
Finding experienced and trained physician investigators will become more of a challenge in the future as new technologies and advances in genomics increase the number of drugs in development. 8,000 In just a few short years, this will be the projected short fall of clinical investigators. In fact...
By Denise Myshko • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
We invite you to explore the digital edition of PharmaVOICE magazine. The interactive format allows you to easily read, share with friends, and click on podcasts, videos, webinars, whitepapers, and Website links to access additional resources. Getting started with your digital edition is this eas...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Electronic Data Capture Turns a Corner ... At Last!
Dennis Constantinou, Senior Director, Oracle Health Sciences New systems that make trial participation easier for investigation sites spur adoption. Today, setting up an EDC system at an investigative site requires only a standard PC with a Web browser and an Internet connection. With the average...
By Dennis Constantinou • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Harriet Robinson: A Shot of Daring
Throughout her life and career, Dr. Harriet Robinson has dared to take on challenges. Today, she is focusing her skills and determination on one of the most sought-after goals in global healthcare: developing a vaccine to prevent HIV/AIDS. After almost 40 years in the lab, Dr. Harriet Robinson is...
By Kim Ribbink • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Video Detailing: 10 Years in the Making
With the proliferation of broadband and advances in technology, e-promotional and educational online activities are on the rise. Detail videos may not have revolutionized the pharma industry in quite the way MTV has revolutionized the music industry, but the medium is gaining traction 10 years af...
By Robin Robinson • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
We are honored to receive this prestigious Enterprise award from Eastern Technology Council, says Robert Broeze, Ph.D., President and CEO of Laureate Pharma. Dr. Broeze, who is with Dr. Michiel Ultee, VP of Process Sciences, in front of an Applikon 20L Bioreactor, says the award validates the com...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL William GARBARINI Jr. Ferring Promotes Head of Orthopedics and Urology Business Ferring Pharmaceuticals has promoted William Garbarini Jr. to VP of its orthopedics and urology business unit, recently formed by the merging of these clinical product areas. Mr. Garbarini was formerly exe...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Lathian Health Offers Closed-Loop Promotion Tool Informa Launches CRM/ROI Tracking Solution Verticals onDemand Offers Analytics and Reporting Solution OpenQ Unveils KOL Solutions Tibco Spotfire Solution Speeds Dru...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
What's New
FemmePharma Global Healthcare Inc. is devoted to developing drugs for diseases and disorders disproportionately affecting women. For more information, visit femmepharma.com. The International Society for Medical Publication Professionals (ISMPP) is a not-for-profit organization for medical public...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry U.S. Biochip Market to Reach $2.5 Billion in 2012 U.S. demand for biochip products and services is forecast to grow 9.9% annually, to $2.5 billion in 2012, led by uses in drug discovery and epidemiological research. According ...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
When it comes to making drugs safer, cheaper, and more effective, few fields have shown more promise than molecular diagnostics. But the full potential of this revolutionary area of medical research has yet to be reached, not because of technological barriers — although they do exist — but becaus...
By Peter Pitts • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
UpFront Milestones Almac turns 20 Dr. Robert Dunlop, president and managing director of Almac Clinical Services (left), and Sir Allen McClay, chairman of Almac Group, celebrate the division’s 20th anniversary. Almac Clinical Services, one of the key divisions at Almac Group, has grown to become t...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
ON THE COVER Partnering for Success In these times of adversity, strategic alliances become even more crucial than ever for survival. FEATURES No Pens or Mugs? No Problem. The industry is discovering it won’t lose the ability to message effectively under the new PhRMA code. The Green o...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
The Benefits of Prelaunch Access
Contributed by Natalie Douglas, CEO, IDIS Prelaunch access to drugs can provide months and perhaps years of treatment for patients with unmet medical needs when all other therapeutic options have failed or no other options are available. The benefits of named- patient programs are best realized w...
By Natalie Douglas • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Sirtris’ Dr. Michelle Dipp discusses maintaining corporate culture while integrating cutting-edge science and technology. Biotech business leader Michelle Dipp, M.D., Ph.D., has transitioned from a scientific background — with a medical degree and a Ph.D. — to the corporate side of the life-scien...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Alex Gorsky Sheri McCoy Johnson & Johnson Shifts Executives Global healthcare company Johnson & Johnson has appointed Alex Gorsky worldwide chairman, surgical care group, with responsibility for the surgical franchises Ethicon, Ethicon Endo-Surgery, and DePuy, as well ...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Cost Deters Cancer Patients from Seeking Treatment In addition to considerable physical and emotional burdens, cancer patients must also shoulder costly treatments resulting from their disease. A recent Thomson Reuters survey shows that the financial repercussions of cancer are taking a toll on p...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Doctors' Choice Awards
Identifying POWERful MEDICAL ADVERTISING 6th Annual Program Generated Responses From More Than 5,700 Physicians Dusa’s ClindaReach and Pfizer’s Chantix Highest Scoring Ads ClindaReach Category: Highest-Scoring Ad (Specialist Audience) Marketer: Dusa Agency: Topin & Associates Chantix Category...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Patient Recruitment
RESEARCH & Development BY DENISE MYSHKO Patient Recruitment The Continuing Saga of Patient-Recruitment Bottlenecks If patient recruitment wasn’t already hard enough, larger, more complex trials have made the enrollment of patients even more challenging. Clinical-trial patient recruitment and ...
By Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Personalized Medicine
RESEARCH & Development PERSONALIZED MEDICINE The Right Dose at the Right time BY DENISE MYSHKO Obstacles and challenges still remain to make the vision of personalized medicine a reality. Despite some early successes, the development of targeted medicines and pharmacogenomics-based testing ha...
By Denise Myshko • Nov. 22, 2008
Previous
